Purpose: Investigating the efficacy of intraoperative fractionated intravenous esketamine in the prevention of rebound pain after cessation of thoracic paravertebral nerve blockade. Methods: One hundred and twenty patients who underwent elective thoracoscopic lobectomy were selected for the study and were randomly divided into two groups, the esketamine group was given 0.5 mg/kg and 0.3 mg/kg of esketamine at the induction of anaesthesia and 30 minutes before the end of the operation, respectively, and the control group was given an equal amount of saline. The incidence of rebound pain (RP) 7 days after surgery and postoperative recovery were compared between the two groups. Results: The NRS pain scores at 24 and 48 hours postoperatively in the esketamine group were significantly lower than those in the control group (P < 0.05). The incidence of postoperative rebound pain was significantly lower in the esketamine group than in the control group (P < 0.05). The consumption of sufentanil was less in the esketamine group in the postoperative 48 hours (P < 0.05). Postoperative recovery was compared between the two groups and the difference was not statistically significant. Conclusion: Intravenous esketamine reduces postoperative pain scores, decreases the incidence of rebound pain after cessation of thoracic paravertebral block, and reduces opioid consumption.
Background: Laparoscopic radical resection of gastrointestinal cancer is associated with a high incidence of postoperative catheter-related bladder discomfort (CRBD). Studies on the benefits of magnesium sulfate intravenous infusion during the perioperative period post-laparoscopic surgery are yet lacking. Methods: A total of 88 gastrointestinal cancer male patients scheduled for laparoscopic radical resection were randomly divided into two groups: normal saline (control) and magnesium. In the magnesium group, a 40 mg/kg loading dose of intravenous magnesium sulfate was administered for 10 min just after the induction of anesthesia, followed by continuous intravenous infusion of 15 mg/kg/h magnesium sulfate until the end of the surgery; the control group was administered the same dose of normal saline. Subsequently, 2 μg/kg sufentanil was continuously infused intravenously by a postoperative patient-controlled intravenous analgesia (PCIA) device. The primary outcome was the incidence of CRBD at 0 h after the surgery. The secondary outcomes included incidence of CRBD at 1, 2, and 6 h postsurgery, the severity of CRBD at 0, 1, 2, and 6 h postsurgery. Remifentanil requirement during surgery, sufentanil requirement within 24 h postsurgery, the postoperative numerical rating scale (NRS) score at 48 h after the surgery, magnesium-related side effects and rescue medication (morphine) requirement were also assessed. Results: The incidence of CRBD at 0, 1, 2, and 6 h postoperatively was lower in the magnesium group than the control group (0 h: P = 0.01; 1 h: P = 0.003; 2 h: P = 0.001; 6 h: P = 0.006). The incidence of moderate to severe CRBD was higher in the control group at postoperative 0 and 1 h (0 h: P = 0.002; 1 h: P = 0.028), remifentanil requirement during surgery were significantly lower in the magnesium group than the control group. Sufentanil requirements during the 24 h postoperative period were significantly lower in the magnesium group than the control group. The NRS score was reduced in the magnesium group compared to the control group in the early postoperative period. Magnesium-related side effects and rescue medication (morphine) did not differ significantly between the two groups. Conclusions: Intravenous magnesium sulfate administration reduces the incidence and severity of CRBD and remifentanil requirement in male patients undergoing radical resection of gastrointestinal cancer. Also, no significant side effects were observed. Trial registration: Chictr.org.cn ChiCTR2100053073. The study was registered on 10/11/2021.
Double-lumen tube (DLT) intubation is frequently performed for thoracic surgery, and a fiberoptic bronchoscopy (FOB) can improve the success rate of correct placement. Disposcope endoscope-guided DLT intubation was recently introduced and has a high first-attempt success rate. We tested whether compared with FOB-guided DLT intubation, disposcope endoscope-guided DLT intubation results in a non-inferior first-attempt success rate. A total of 181 patients who underwent thoracic surgery and required DLT intubation were randomly assigned to two groups: FOB guidance (FOB group) and disposcope endoscope guidance (DE group). The primary outcome was the first-attempt success rate. The secondary outcomes included the number of attempts, first intubation time, intraoperative dislodgement, and changes in the mean arterial pressure (MAP) and heart rate (HR) after intubation. The difference in the first DLT attempt success rate between the groups did not exceed the non-inferiority margin of 8% (DE group: 91.3% vs. FOB group: 89.9%; difference: 1.4%, 95% exact CI: −7.1–9.9%). The difference in the number of multiple DLT attempts also did not differ between the DE group and the FOB group (two attempts: 6.5% vs. 6.7%, P = 0.953; three attempts: 2.2% vs. 3.4%, P = 0.120). The first DLT intubation time [66 (55–86) vs. 77 (64–98) s, P = 0.010] was significantly shorter in the DE group. No significant differences were observed in the intraoperative dislodgement or changes in the MAP or HR after intubation (P > 0.05). Compared with FOB guidance, disposcope endoscope guidance provided a non-inferior first-attempt success rate and a shorter first intubation time for DLT intubation.
1 January 2025 in Medical Devices: Evidence and Research
Purpose: Lung ultrasound (LUS) is increasingly utilized in the field of anesthesiology due to its focused, quick application and the advantage of not exposing patients to ionizing radiation. This study aims to analyze the status and trends in this area from a macroscopic perspective. Methods: A bibliometric analysis was conducted using the Web of Science (WoS) Core Collection. The analysis and visualization were performed using WoS, Excel, VOSviewer, and CiteSpace. Parameters such as publications, countries, institutions, journals, and keywords were analyzed. Results: A total of 133 articles published over the last 10 years were analyzed to clarify the current status and future trends on the use of LUS in anesthesiology. The number of publications increased markedly from May 1, 2014, to April 30, 2024. China is the highest productive country, while the USA had the highest number of citations. In the institution, Seoul National University in South Korea published the most articles and had the highest number of citations. Kim Jin-Tae emerged as the most prolific and influential author. BMC Anesthesiology and the Journal of Cardiothoracic and Vascular Anesthesia were identified as the most popular journals in the field. Keywords such as “atelectasis”, “mechanical ventilation”, and “pulmonary complications” were closely related to the use of LUS in anesthesiology. Conclusion: This study provides a comprehensive analysis of research on the use of LUS in anesthesiology, highlighting the growing interest in LUS and its relevance to pulmonary complications.